Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case–control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium

被引：0
|
作者：
A Martino
D Campa
G Buda
J Sainz
R García-Sanz
K Jamroziak
R M Reis
N Weinhold
M Jurado
R Ríos
Z Szemraj-Rogucka
H Marques
J Szemraj
A Stein
R Kumar
E Orciuolo
F Gemignani
S Landi
H Goldschmidt
M Petrini
C Dumontet
F Canzian
A M Rossi
机构：
[1] Genomic Epidemiology Group,Department of Hematology
[2] German Cancer Research Center DKFZ,Hematology Division
[3] Oncology,Department of Hematology
[4] Transplants and Advanced Technologies,Department of Internal Medicine
[5] Section of Hematology,Department of Medical Biochemistry
[6] Pisa University,Division of Molecular Genetic Epidemiology
[7] Genomic Oncology Area,Department of Biology
[8] Genyo - Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research,undefined
[9] Virgen de las Nieves University Hospital,undefined
[10] University Hospital of Salamanca,undefined
[11] Universidad de Salamanca-Consejo Superior de Investigaciones Científicas,undefined
[12] Medical University of Lodz,undefined
[13] Life and Health Sciences Research Institute (ICVS),undefined
[14] School of Health Sciences,undefined
[15] University of Minho,undefined
[16] Molecular Oncology Research Center,undefined
[17] Barretos Cancer Hospital,undefined
[18] Medizinische Klinik V,undefined
[19] Universitaetsklinikum Heidelberg,undefined
[20] Medical University of Lodz,undefined
[21] German Cancer Research Center DKFZ,undefined
[22] Section of Genetics,undefined
[23] University of Pisa,undefined
[24] INSERM U590,undefined
[25] Laboratoire de Cytologie Analytique,undefined
[26] Faculte de Medecine Rockefeller,undefined
[27] Universite Claude Bernard Lyon I,undefined
来源：
Leukemia | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1419 / 1422
页数：3
相关论文
共 50 条
  • [1] Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium
    Martino, A.
    Campa, D.
    Buda, G.
    Sainz, J.
    Garcia-Sanz, R.
    Jamroziak, K.
    Reis, R. M.
    Weinhold, N.
    Jurado, M.
    Rios, R.
    Szemraj-Rogucka, Z.
    Marques, H.
    Szemraj, J.
    Stein, A.
    Kumar, R.
    Orciuolo, E.
    Gemignani, F.
    Landi, S.
    Goldschmidt, H.
    Petrini, M.
    Dumontet, C.
    Canzian, F.
    Rossi, A. M.
    LEUKEMIA, 2012, 26 (06) : 1419 - 1422
  • [2] Erratum: Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case—control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium
    A Martino
    D Campa
    G Buda
    J Sainz
    R García-Sanz
    K Jamroziak
    R M Reis
    N Weinhold
    M Jurado
    R Ríos
    Z Szemraj-Rogucka
    H Marques
    J Szemraj
    A Stein
    R Kumar
    E Orciuolo
    F Gemignani
    S Landi
    H Goldschmidt
    M Petrini
    C Dumontet
    F Canzian
    A M Rossi
    Leukemia, 2013, 27 : 1615 - 1616
  • [3] Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium (vol 26, pg 1419, 2012)
    Martino, A.
    Campa, D.
    Buda, G.
    Sainz, J.
    Garcia-Sanz, R.
    Jamroziak, K.
    Reis, R. M.
    Weinhold, N.
    Jurado, M.
    Rios, R.
    Szemraj-Rogucka, Z.
    Marques, H.
    Szemraj, J.
    Stein, A.
    Kumar, R.
    Orciuolo, E.
    Gemignani, F.
    Landi, S.
    Goldschmidt, H.
    Petrini, M.
    Dumontet, C.
    Canzian, F.
    Rossi, A. M.
    LEUKEMIA, 2013, 27 (07) : 1615 - 1616
  • [4] Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance
    Bruhn, Oliver
    Cascorbi, Ingolf
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (10) : 1337 - 1354
  • [5] ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
    Bruckmueller, Henrike
    Cascorbi, Ingolf
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (04) : 369 - 396
  • [6] Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo
    Colombo, S
    Soranzo, N
    Rotger, M
    Sprenger, R
    Bleiber, G
    Furrer, H
    Buclin, T
    Goldstein, D
    Décosterd, L
    Telenti, A
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (09): : 599 - 608
  • [7] Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine
    Neumanova, Zuzana
    Cerveny, Lukas
    Ceckova, Martina
    Staud, Frantisek
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (01) : 28 - 38
  • [8] Karanjin interferes with ABCB1, ABCC1, and ABCG2
    Michaelis, Martin
    Rothweiler, Florian
    Nerreter, Thomas
    Sharifi, Mohsen
    Ghafourian, Taravat
    Cinatl, Jindrich, Jr.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (01): : 92 - 105
  • [9] ABCB1, ABCC1 AND ABCG2 Transporters Expression in 180 Primary Retinoblastoma
    Cabrera-Munoz, Lourdes
    Ponce, M.
    Sadowinski-Pine, Stanislaw
    Manuela, Orjuela
    Gomez, Alejandro
    Loyola, Ofelia
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1602 - 1602
  • [10] Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo
    Hill, Christopher R.
    Jamieson, David
    Thomas, Huw D.
    Brown, Colin D. A.
    Boddy, Alan V.
    Veal, Gareth J.
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (01) : 29 - 37
12345